¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"renal fraction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • acute renal failure
    ±Þ¼ºÄáÆÏ±â´É»ó½Ç, ±Þ¼º½ÅºÎÀü
  • back pressure renal atrophy
    ¿ª¾ÐÄáÆÏÀ§Ãà, ¿ª¾Ð½ÅÀåÀ§Ãà
  • branchio-oto-renal syndrome
    ¾Æ°¡¹Ì±ÍÄáÆÏÁõÈıº
  • cystic renal dysplasia
    ³¶¼ºÄáÆÏÇü¼ºÀÌ»ó, ³¶¼º½ÅÀåÇü¼ºÀÌ»ó
  • chronic renal failure
    ¸¸¼ºÄáÆÏ±â´É»ó½Ç, ¸¸¼º½ÅºÎÀü
  • effective renal blood flow
    À¯È¿ÄáÆÏÇ÷·ù·®, À¯È¿½ÅÀåÇ÷·ù·®
  • effective renal plasma flow
    À¯È¿ÄáÆÏÇ÷ÀåÀ¯·®, À¯È¿½ÅÀåÇ÷ÀåÀ¯·®
  • hemorrhagic fever with renal syndrome
    ÃâÇ÷¿­ÄáÆÏÁõÈıº, ÃâÇ÷¿­½ÅÁõÈıº
  • necrotizing renal papillitis
    ±«»çÄáÆÏÀ¯µÎ¿°, ±«»ç½ÅÀåÀ¯µÎ¿°
  • radionuclide renal scan
    ¹æ»ç¼ºÇÙÁ¾ÄáÆÏ½ºÄµ, ¹æ»ç¼ºÇÙÁ¾½ÅÀ彺ĵ
  • renal
    ÄáÆÏ-, ½ÅÀå-
  • renal ablation glomerulosclerosis
    ÄáÆÏÀýÁ¦Å丮±»À½Áõ, ½ÅÀýÁ¦»ç±¸Ã¼°æÈ­Áõ
  • renal acidosis
    ½ÅÀ强»êÁõ
  • renal adenocarcinoma
    ÄáÆÏ»ù¾ÏÁ¾, ½ÅÀå¼±¾ÏÁ¾
  • renal agenesis
    ÄáÆÏ¹«¹ß»ý, ½ÅÀ幫¹ß»ý
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • renal disease
    ÄáÆÏº´, ½ÅÀ庴
  • renal disorder
    ÄáÆÏÀå¾Ö, ½ÅÀåÀå¾Ö
  • acute renal failure
    ±Þ¼ºÄáÆÏ±â´É»ó½Ç, ±Þ¼º½ÅºÎÀü(Áõ)
  • chronic renal failure
    ¸¸¼ºÄáÆÏ±â´É»ó½Ç, ¸¸¼º½ÅºÎÀü(Áõ)
  • renal infundibulum
    ÄáÆÏ´ë·Õ
  • renal papillary necrosis
    ÄáÆÏÀ¯µÎ±«»ç
  • renal osteodystrophy
    ÄáÆÏÅ¿»ÀÇü¼ºÀå¾Ö, ½ÅÀ强°ñÇü¼ºÀå¾Ö
  • renal papilla
    ÄáÆÏÀ¯µÎ, ½ÅÀåÀ¯µÎ
  • renal pelvis
    ÄáÆÏ±ò¶§±â, ½Å¿ì
  • renal
    ÄáÆÏ-, ½ÅÀå-
  • hemorrhagic fever with renal syndrome
    ÃâÇ÷¿­ÄáÆÏÁõÈıº
  • renal scar
    ÄáÆÏÈäÅÍ, ½ÅÀåÈäÅÍ
  • renal scan
    ÄáÆÏ½ºÄµ, ½ÅÀ彺ĵ
  • renal stone
    ÄáÆÏµ¹
  • renal tuberculosis
    ÄáÆÏ°áÇÙ, ½ÅÀå°áÇÙ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • renal acidosis
    ÄáÆÏ»êÁõ
  • renal adenocarcinoma
    ÄáÆÏ»ù¾ÏÁ¾
  • renal adenoma
    ÄáÆÏ»ùÁ¾
  • renal aminoaciduria
    ÄáÆÏ¾Æ¹Ì³ë»ê´¢, ½ÅÀ徯¹Ì³ë»ê´¢
  • renal anasarca
    ÄáÆÏÀü½ÅºÎÁ¾, ½ÅÀ强Àü½ÅºÎÁ¾
  • renal aplasia
    ÄáÆÏ¹«Çü¼º
  • renal apoplexy
    ÄáÆÏµÈÃâÇ÷
  • renal arteriogram
    ÄáÆÏµ¿¸ÆÁ¶¿µ»ó, ½ÅÀ嵿¸ÆÁ¶¿µ»ó
  • renal artery
    ÄáÆÏµ¿¸Æ, ½ÅÀ嵿¸Æ
  • renal autotransplantation
    ÄáÆÏÀÚ°¡À̽Ä, ½ÅÀåÀÚ°¡À̽Ä
  • renal cortical adenoma
    ÄáÆÏ°ÑÁú»ùÁ¾
  • renal tubular acidosis
    ÄáÆÏ´¢¼¼°ü»êÁõ
  • crossed renal ectopia
    ¾ù°¥¸°ÄáÆÏµý°÷Áõ
  • cystic renal dysplasia
    ³¶¼ºÄáÆÏÇü¼ºÀÌ»ó, ³¶¼º½ÅÀåÇü¼ºÀÌ»ó
  • cystic renal medulla
    ÁÖ¸Ó´ÏÄáÆÏ¼ÓÁú, ÁָӴϽżöÁú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ERPF=£¾effective renal plasma flow
    À¯È¿½ÅÇ÷·ù·®.
  • RFI=>renal failure index
    ½ÅºÎÀüÁö¼ö
  • RPF => renal plasma flow
    ½ÅÇ÷Àå·ù(·®)
  • accessory renal calyx
    ºÎ(Á¸)½Å¹è
  • acute renal failure
    ±Þ¼º ½ÅºÎÀü(Áõ)(¡­ãìÝÕîïñø).
  • aluminium,renal osteodystrophy
    ½Å¼º °ñÀÌ¿µ¾çÁõ(ãìàõ Íéì£ç½å×ñø)
  • aortic renal ganglia
    ´ëµ¿¸ÆÄáÆÏ½Å°æÀý
  • arcuate renal tubule
    Ȱ²Ã¼¼°ü
  • gland of renal pelvis
    ÄáÆÏ±ò¶§±â»ù
  • greater renal calices<³ª> calix renalis major
    Å«(½ÅÀå)¼úÀÜ, ´ë½Å¹è(ÓÞãìÛÊ).
  • hemorrhagic fever with renal syndrome, HFRS
    ½ÅÁõÈıº ÃâÇ÷¿­
  • hemorrhagic fever with renal syndrome, HFRS
    ½ÅÁõÈÄ ÃâÇ÷¿­
  • hepato renal echo contrast
    °£ ½ÅÀå ¿¡ÄÚ ´ëÁ¶
  • hepato-renal echo contrast
    °£-½ÅÀå (ÊÜ-ãìíô) ¿¡ÄÚ ´ëÁ¶ (ÓßðÎ), °£-½ÅÀå (ÊÜ-ãì
  • heteroplasia (renal cartilage)
    ´Ù¸¥Á¶Á÷Çü¼º (ÄáÆÏ¿¬°ñ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • labile fraction
    ºÒ¾ÈÁ¤ºÐȹ(¡­ÝÂüñ).
  • mixed fraction
    ´ëºÐ¼ö(ÓáÝÂâ¦).
  • mixed fraction
    ´ëºÐ¼ö(ËÀËÓËà).
  • molar fraction
    ¸ôºÐÀ²(¡­ÝÂëÒ).
  • multiple fraction per day, MFD
    ÀÏÀÏ´ÙºÐÇÒÁ¶»ç¹ý
  • partial fraction
    ºÎºÐºÐ¼ö<ºÐȹ>.
  • plasma protein fraction =PCC
    Ç÷Àå´Ü¹éºÐȹ
  • recombination fraction
    ÀçÁ¶Çպмö(î¢ðàùêÝÂâ¦)
  • reducible fraction
    ¹Ì¾àºÐ¼ö(Ú±å³ÝÂâ¦).
  • reduction of fraction
    ¾àºÐ(å³ÝÂ).
  • regurgitant fraction
    ¿ª·ùºÐȹ.
  • tubular rejection fraction ratio
    ½Å¼¼´¢°ü°ÅºÎºÐȹ·ü.
  • volume fraction
    ¿ëÀûºÐȹ.
  • accessory renal calyx
    ºÎ(Á¸)½Å¹è
  • acute renal failure
    ±Þ¼º ½ÅºÎÀü(Áõ)(¡­ãìÝÕîïñø).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Renal sinus
    ÄáÆÏµ¿±¼
    [¿¾ ¿ë¾î] ½Åµ¿
  • Renal arteries
    ÄáÆÏµ¿¸Æ
    [¿¾ ¿ë¾î] ½ÅÀ嵿¸Æ
  • Renal artery
    ÄáÆÏµ¿¸Æ
    [¿¾ ¿ë¾î] ½Åµ¿¸Æ
  • Renal surface
    ÄáÆÏ¸é
    [¿¾ ¿ë¾î] ½Å¸é
  • Renal hilum
    ÄáÆÏ¹®
    [¿¾ ¿ë¾î] ½Å¹®
  • Renal tubule
    ÄáÆÏ¼¼°ü
    [¿¾ ¿ë¾î] ¿ä¼¼°ü
  • Renal tubules
    ÄáÆÏ¼¼°ü
    [¿¾ ¿ë¾î] ½Å¼¼°ü
  • Renal corpuscle
    ÄáÆÏ¼Òü
    [¿¾ ¿ë¾î] ½Å¼Òü
  • Renal medulla
    ÄáÆÏ¼ÓÁú
    [¿¾ ¿ë¾î] ¼öÁú
  • Renal medulla
    ÄáÆÏ¼ÓÁú
    [¿¾ ¿ë¾î] ½Å¼öÁú
  • Renal calices
    ÄáÆÏ¼úÀÜ
    [¿¾ ¿ë¾î] ½Å¹è
  • Renal calyx
    ÄáÆÏ¼úÀÜ
    [¿¾ ¿ë¾î] ½Å¹è
  • Renal plexus
    ÄáÆÏ½Å°æ¾ó±â
    [¿¾ ¿ë¾î] ½Å½Å°æÃÑ
  • Renal ganglia
    ÄáÆÏ½Å°æÀý
    [¿¾ ¿ë¾î] ½Å½Å°æÀý
  • Renal lobe
    ÄáÆÏ¿±
    [¿¾ ¿ë¾î] ½ÅÀå¼Ò¿±
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mole fraction
    ¸ô ºÐȹ(ÝÂüñ)
  • omega fraction
    ¿À¸Þ°¡ ºÐȹ(ÝÂüñ)
  • particulate fraction
    ÀÔÀÚ ºÐȹ(Ø£í­ÝÂüñ)
  • pH 5 fraction
    pH 5 ºÐȹ(ÝÂüñ)
  • pre-beta fraction
    ÇÁ·¹º£Å¸ºÐȹ(ÝÂüñ)
  • saponifiable fraction
    °¡(ʦ)ºñ´©È­ ºÐȹ(ÝÂüñ)
  • saturation fraction
    Æ÷È­ ºÐȹ(øéûùÝÂüñ)
  • S-100 fraction
    S-100 ºÐȹ(ÝÂüñ)
  • soluble fraction
    °¡¿ë ºÐȹ(ʦéÁÝÂüñ)
  • subcellular fraction
    ¼¼Æ÷ÇÏ ºÐȹ(á¬øàù»ÝÂüñ)
  • volume fraction
    ¿ëÀû ºÐȹ(é»îÝÝÂüñ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • renal osteodytrophy
    ½Å¼º°ñÀÌ¿µ¾çÁõ
  • renal papillary necrosis
    ½ÅÀ¯µÎ±«»ç
  • renal pelvis
    ½Å¿ì
  • renal pyramid
    ½ÅÀåÇǶó¹Ô, ½ÅÃßü
  • renal rickets
    ½Å¼º ±¸·çº´
  • renal scanning
    ½ÅÁÖ»ç¹ý
  • renal scintigraphy
    ½Å½ÃƼ±×·¡ÇÇ
  • renal transplantation
    ½ÅÀ̽Ä
  • renal tubular acidosis
    ½Å´¢¼¼°ü»êÁõ
  • renal vein
    ½ÅÁ¤¸Æ
  • renal vein thrombosis
    ½ÅÁ¤¸ÆÇ÷ÀüÁõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
RVRA renal vein rein activity; renal venous renin assay
SRF severe renal failure; skin reactive factor; somatotropin-releasing factor; split renal function; sub...
CK-MB Creatine Kinase MB Fraction
EF study Ejection-Fraction study
FiO2 Fraction of Inspired Oxygen; ÈíÀÔ »ê¼Ò ³óµµ
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
Fr. Fraction
F1 Fraction 1
F-2 Fraction 2
F3 Fraction 3
FI Fraction I
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • renal abscess
    ½Å ³ó¾ç
  • renal adenocarcinoma
    ½Å ¼±¾Ï
  • renal agenesis
    ½Å ¹«Çü¼ºÁõ, ½Å ¹«¹ßÀ°Áõ
  • renal amino aciduria
    ½Å¼º ¾Æ¹Ì³ë»ê´¢
  • renal anasarca
    ½Å¼º Àü½Å ¼öÁ¾
  • renal angle
    ½Å°¢
  • renal aplasia
    ½Å¹«Çü¼º, ½Å ¹«Çü¼ºÁõ
  • renal arterial occlusion
    ½Åµ¿¸Æ Æó»ö
  • renal arteriography
    ½Åµ¿¸Æ Á¶¿µ¼ú
  • renal artery
    ½ÅÀå µ¿¸Æ, ½Åµ¿¸Æ, ÄáÆÏ µ¿¸Æ
    º¹µ¿¸ÆÀÇ ±½Àº °¡Áö¿¡¼­ Á¦ 2¿äÃß ³ôÀÌ¿¡¼­ Á¿ì 1´ë°¡ ºÐ±âÇϰí ÀÖ´Ù.
  • renal artery embolization
    ½Åµ¿¸Æ Æó¼â¼ú
  • renal artery stenosis
    ½Åµ¿¸Æ ÇùÂø
  • renal atheroembolic disease
    ½ÅÁ×»ó Àü»öº´, ½ÅÁ×Á¾ »öÀüº´
  • renal autonomic plexus
    ½Å ÀÚÀ² ½Å°æÃÑ
  • renal azotemia
    ½Å¼º °íÁú¼Ò Ç÷Áõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
acute renal failure <nephrology> A sudden decline in renal function may be triggered by a number of acute disease processes.
Examples include sepsis (infection), shock, trauma, kidney stones, kidney infection, drug toxicity (aspirin or lithium), poisons or toxins (drug abuse) or after injection with an iodinated contrast dye (adverse effect).
Chronic renal failure represents a slow decline in kidney function over time. Chronic renal failure may be caused by a number of disorders which include long-standing hypertension, diabetes, congestive heart failure, lupus or sickle cell anaemia. Both forms of renal failure result in a life-threatening metabolic derangement.
(27 Sep 1997)
aminoaciduria, renal Impairment of renal tubular transport of amino acids.
(12 Dec 1998)
back-pressure renal atrophy <radiology> Caliectasis without obstruction, due to repeated episodes of obstruction, gradual loss of renal pyramids
(12 Dec 1998)
base of renal pyramid The outer broad part of a renal pyramid that lies next to the cortex.
Synonym: basis pyramidis renis.
(05 Mar 2000)
branchio-oto-renal syndrome <syndrome> An autosomal dominant disorder manifested by various combinations of preauricular pits, branchial fistulae or cysts, lacrimal duct stenosis, hearing loss, structural defects of the outer, middle, or inner ear, and renal dysplasia. Associated defects include asthenic habitus, long narrow facies, constricted palate, deep overbite, and myopia. Hearing loss may be due to mondini type cochlear defect and stapes fixation.
(12 Dec 1998)
capsular branches of renal artery <anatomy, artery> Branches arising from the renal artery outside of the kidney that are distributed to the renal capsule.
Synonym: rami capsulares arteriae renalis.
(05 Mar 2000)
captopril renal scan <radiology> In a kidney with a lesion in the afferent arteriole (e.g. Atherosclerotic plaque), reflex constriction of the efferent arteriole occurs through angiotensin system thus maintaining renal perfusion. ACE inhibition prevents constriction of efferent arteriole. Therefore, perfusion is decreased to a kidney with afferent lesions and the renal scan to looks WORSE. Bottom line: renal scans appear WORSE with captopril administration if there is a lesion in the afferent arteriole. See: renal artery stenosis
(12 Dec 1998)
carcinoma, renal cell Carcinoma of the renal parenchyma usually occurring in middle age or later and composed of tubular cells in varying arrangements. It was first described in 1826. Possible causal factors are environmental, hormonal, cellular, and genetic. Smoking is a definite risk factor and obesity is associated with increased risk. Renal cell carcinoma accounts for approximately 3% of adult cancer; the male-female ratio is 2:1. It is more common among urban residents than rural.
(12 Dec 1998)
renal <anatomy> Pertaining to the kidney, nephric.
(18 Nov 1997)
renal adenocarcinoma <radiology> Hypernephroma, renal cell carcinoma, arises from proximal collecting tubule, 10% bilateral adenocarcinoma types: papillary, alveolar, onchocytoma vascularity, 85% hypervascular (require pre-op embolization), 10% hypovascular (usually papillary type), 5% avascular associated with: tuberous sclerosis, von Hippel-Lindau syndrome see also: staging
(12 Dec 1998)
renal adenocarcinoma: staging <radiology> Typical presentation: Haematuria . . . . . 70% Fever . . . . . . . 16% Pain . . . . . . . . 50% Polycythemia . . . . 3% Palpable mass . . . 20% Anatomic staging (TNM): T1 Small tumour, kidney not enlarged T2 Large tumour, contained within renal capsule T3 Extension into perinephric fat or renal vein T4 Invasion of adjacent organs
(12 Dec 1998)
renal adenocarcinoma: vascularity <radiology> 85% hypervascular (require pre-op embolization), 10% hypovascular (usually the papillary type), 5% avascular also: 10% are bilateral
(12 Dec 1998)
renal agenesis <radiology> Associated with, duplicated vagina and/or uterus (mullerian duct anomaly), seminal vesicle cysts
(12 Dec 1998)
renal agents Drugs used for their effects on the kidneys' regulation of body fluid composition and volume. The most commonly used are the diuretics. Also included are drugs used for their antidiuretic and uricosuric actions, for their effects on the kidneys' clearance of other drugs, and for diagnosis of renal function.
(12 Dec 1998)
renal amyloidosis Renal deposits of amyloid, especially in glomerular capillary walls, which may cause albuminuria and the nephrotic syndrome.
Synonym: amyloid nephrosis.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á